# SMART Diets for MASLD

> **NCT07459504** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Corewell Health West** · enrollment: 102 (estimated)

## Conditions studied

- Metabolic-dysfunction Associated Steatotic Liver Disease

## Interventions

- **DRUG:** Essential Amino Acids Supplementation intervention
- **OTHER:** Low sugar diet

## Key facts

- **NCT ID:** NCT07459504
- **Lead sponsor:** Corewell Health West
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-26
- **Primary completion:** 2029-12-26
- **Final completion:** 2030-12-26
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07459504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07459504, "SMART Diets for MASLD". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07459504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*